C. Kronman

1.7k total citations
17 papers, 1.4k citations indexed

About

C. Kronman is a scholar working on Pharmacology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, C. Kronman has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 11 papers in Molecular Biology and 11 papers in Computational Theory and Mathematics. Recurrent topics in C. Kronman's work include Cholinesterase and Neurodegenerative Diseases (13 papers), Computational Drug Discovery Methods (11 papers) and Bacteriophages and microbial interactions (4 papers). C. Kronman is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (13 papers), Computational Drug Discovery Methods (11 papers) and Bacteriophages and microbial interactions (4 papers). C. Kronman collaborates with scholars based in Israel, United States and Poland. C. Kronman's co-authors include Avigdor Shafferman, Baruch Velan, Arie Ordentlich, Dov Barak, Moshe Leitner, Naomi Ariel, Yehuda Flashner, Sara Cohen, Haim Grosfeld and Dino Marcus and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Biochemical Journal.

In The Last Decade

C. Kronman

17 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Kronman Israel 15 1.1k 715 641 342 330 17 1.4k
Yehuda Flashner Israel 21 814 0.8× 531 0.7× 936 1.5× 351 1.0× 241 0.7× 45 1.8k
Dino Marcus Israel 13 664 0.6× 373 0.5× 355 0.6× 405 1.2× 141 0.4× 18 961
E. Gary United States 10 1.1k 1.1× 823 1.2× 518 0.8× 169 0.5× 643 1.9× 21 1.7k
Alessandra Nurisso Switzerland 25 330 0.3× 138 0.2× 1000 1.6× 252 0.7× 458 1.4× 48 1.9k
Edwin H. Rydberg Canada 10 185 0.2× 176 0.2× 868 1.4× 161 0.5× 193 0.6× 11 1.5k
Polamarasetty Aparoy India 16 215 0.2× 240 0.3× 470 0.7× 58 0.2× 257 0.8× 35 947
Rakesh S. Joshi India 21 83 0.1× 191 0.3× 643 1.0× 275 0.8× 179 0.5× 76 1.4k
Samir Yahiaoui France 22 398 0.4× 182 0.3× 472 0.7× 46 0.1× 435 1.3× 40 1.1k
Tyler W. H. Backman United States 12 142 0.1× 188 0.3× 605 0.9× 210 0.6× 66 0.2× 22 1.1k
Michele Tonelli Italy 24 210 0.2× 243 0.3× 542 0.8× 84 0.2× 750 2.3× 62 1.6k

Countries citing papers authored by C. Kronman

Since Specialization
Citations

This map shows the geographic impact of C. Kronman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Kronman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Kronman more than expected).

Fields of papers citing papers by C. Kronman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Kronman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Kronman. The network helps show where C. Kronman may publish in the future.

Co-authorship network of co-authors of C. Kronman

This figure shows the co-authorship network connecting the top 25 collaborators of C. Kronman. A scholar is included among the top collaborators of C. Kronman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Kronman. C. Kronman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mendelson, Itai, Orit Gat, Ronit Aloni-Grinstein, et al.. (2005). Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components. Vaccine. 23(48-49). 5688–5697. 23 indexed citations
2.
Gat, Orit, Itzhak Inbar, Ronit Aloni-Grinstein, et al.. (2003). Use of a Promoter Trap System in Bacillus anthracis and Bacillus subtilis for the Development of Recombinant Protective Antigen-Based Vaccines. Infection and Immunity. 71(2). 801–813. 34 indexed citations
3.
Cohen, Sara, Itai Mendelson, Zeev Altboum, et al.. (2000). Attenuated Nontoxinogenic and Nonencapsulated Recombinant Bacillus anthracis Spore Vaccines Protect against Anthrax. Infection and Immunity. 68(8). 4549–4558. 114 indexed citations
4.
Kronman, C., Baruch Velan, Dino Marcus, et al.. (1995). Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulation. Biochemical Journal. 311(3). 959–967. 49 indexed citations
5.
Ashani, Yacov, Jacob Grunwald, C. Kronman, Baruch Velan, & Avigdor Shafferman. (1994). Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase.. Molecular Pharmacology. 45(3). 555–560. 39 indexed citations
6.
Velan, Baruch, C. Kronman, Yehuda Flashner, & Avigdor Shafferman. (1994). Reversal of signal-mediated cellular retention by subunit assembly of human acetylcholinesterase.. Journal of Biological Chemistry. 269(36). 22719–22725. 11 indexed citations
7.
Shafferman, Avigdor, Arie Ordentlich, Dov Barak, et al.. (1994). Electrostatic attraction by surface charge does not contribute to the catalytic efficiency of acetylcholinesterase.. The EMBO Journal. 13(15). 3448–3455. 69 indexed citations
8.
Kronman, C., Arie Ordentlich, Dov Barak, Baruch Velan, & Avigdor Shafferman. (1994). The “back door” hypothesis for product clearance in acetylcholinesterase challenged by site-directed mutagenesis.. Journal of Biological Chemistry. 269(45). 27819–27822. 45 indexed citations
9.
Barak, Dov, C. Kronman, Arie Ordentlich, et al.. (1994). Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core.. Journal of Biological Chemistry. 269(9). 6296–6305. 156 indexed citations
10.
Lazar, Arye, Shaul Reuveny, C. Kronman, Baruch Velan, & Avigdor Shafferman. (1993). Evaluation of anchorage-dependent cell propagation systems for production of human acetylcholinesterase by recombinant 293 cells. Cytotechnology. 13(2). 115–123. 15 indexed citations
11.
Velan, Baruch, C. Kronman, Arie Ordentlich, et al.. (1993). N-glycosylation of human acetylcholinesterase: effects on activity, stability and biosynthesis. Biochemical Journal. 296(3). 649–656. 83 indexed citations
12.
Ordentlich, Arie, Dov Barak, C. Kronman, et al.. (1993). Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. Journal of Biological Chemistry. 268(23). 17083–17095. 288 indexed citations
13.
Kronman, C., et al.. (1993). Interrelations between assembly and secretion of recombinant human acetylcholinesterase.. Journal of Biological Chemistry. 268(1). 180–184. 46 indexed citations
14.
Shafferman, Avigdor, C. Kronman, Yehuda Flashner, et al.. (1992). Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding.. Journal of Biological Chemistry. 267(25). 17640–17648. 162 indexed citations
15.
Shafferman, Avigdor, Baruch Velan, Arie Ordentlich, et al.. (1992). Substrate inhibition of acetylcholinesterase: residues affecting signal transduction from the surface to the catalytic center.. The EMBO Journal. 11(10). 3561–3568. 194 indexed citations
16.
Velan, Baruch, Haim Grosfeld, C. Kronman, et al.. (1991). The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580—-Ala mutant.. Journal of Biological Chemistry. 266(35). 23977–23984. 84 indexed citations
17.
Honigman, Alik, C. Kronman, Israel Nur, Norman M. Greenberg, & Shlomo Rottem. (1984). Cloning of L-2 DNA in Escherichia coli pOL4 plasmid.. PubMed. 20(9). 793–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026